autologous ovarian cancer immunogene-modified T lymphocytes
Term · Oncology and biomedicine · MLC-T-ONC-011730
A preparation of autologous immunogene modified T lymphocytes (IgT) that have been genetically engineered to be specifically reactive to ovarian cancer (OC) cells, with potential antineoplastic and immunostimulating activities. Upon administration of the autologous OC-IgT cells, the T cells recognize and induce specific toxicity in the OC cells.
| Identifier | MLC-T-ONC-011730 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | OC-IgT cells; autologous human OC-IgT cells |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-011730",
"term": "autologous ovarian cancer immunogene-modified T lymphocytes",
"field": "Oncology and biomedicine",
"definition": "A preparation of autologous immunogene modified T lymphocytes (IgT) that have been genetically engineered to be specifically reactive to ovarian cancer (OC) cells, with potential antineoplastic and immunostimulating activities. Upon administration of the autologous OC-IgT cells, the T cells recognize and induce specific toxicity in the OC cells.",
"synonyms": [
"OC-IgT cells",
"autologous human OC-IgT cells"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/autologous-ovarian-cancer-immunogene-modified-t-lymphocytes/"
}
Record 3,066 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.